60 Biggest Movers From Friday

Gainers

• IVERIC bio, Inc. ISEE shares surged 62.5% to close at $14.12 on Friday after Apellis Pharmaceuticals reported results from its Phase 3 DERBY and OAKS studies in geographic atrophy. IVERIC Bio, a competitor to Apellis, is also working on a product to treat geographic atrophy, called Zimura. Stifel initiated coverage on IVERIC bio with a Buy rating and announced a price target of $22.
• Echo Global Logistics, Inc. ECHO gained 52.3% to settle at $47.70 after the company agreed to be acquired by private equity firm The Jordan Company.
• Affirm Holdings, Inc. AFRM jumped 34.4% to settle at $123.70 after the company reported better-than-expected Q4 sales and issued strong Q1 sales guidance.
• Farmmi, Inc. FAMI jumped 34.4% to close at $0.5750. Farmmi’s subsidiary Zhejiang Forest Food Co Ltd recently won a new product order for its dried whole Shiitake mushrooms.
• Endo International plc ENDP shares rose 32.9% to close at $2.79 after the company said it has settled three consolidated opioid cases pending in Suffolk County Supreme Court in the State of New York. As a result of the settlement, Endo has been severed from the trial.
• SigmaTron International, Inc. SGMA gained 32.6% to settle at $8.30 after the company announced its first-quarter fiscal 2022 financial results.
• Onion Global Limited OG surged 26.2% to close at $6.79. Onion Global, last month, reported $107.90 million in sales this quarter.
• IronNet, Inc. IRNT jumped 24.6% to settle at $21.57.
• T2 Biosystems, Inc. TTOO climbed 23.5% to close at $1.07 after the company announced its T2SARS-CoV-2 panel proved capable of detecting the Mu B.1.621 and Iota B.1.526 variants of the SARS-CoV-2 virus.
• Research Frontiers Incorporated REFR gained 21.5% to settle at $2.88.
• Elite Education Group International Limited EEIQ jumped 20.9% to close at $6.31 after jumping 20% on Thursday.
• Greenlane Holdings, Inc. GNLN climbed 18.4% to close at $3.02.
• Euroseas Ltd. ESEA gained 18.2% to settle at $30.72. Euroseas, last week, announced a new time charter contract for its container vessel M/V Synergy Oakland.
• Camber Energy, Inc. CEI shares jumped 16.9% to close at $1.52 after jumping 31% on Thursday.
• Aterian, Inc. ATER climbed 15.9% to close at $11.80.
• Vince Holding Corp. VNCE gained 15.5% to close at $7.75 after the company reported better-than-expected Q2 results.
• Rubicon Technology, Inc. RBCN rose 15.2% to settle at $10.70.
• Adagio Therapeutics, Inc. ADGI gained 14.9% to close at $53.90. Adagio Therapeutics announced that the independent data monitoring committee (IDMC) has recommended expanding the ADG20 EVADE Phase 2/3 trial for COVID-19.
• The Dixie Group, Inc. DXYN climbed 14.8% to close at $5.11.
• Arbutus Biopharma Corporation ABUS climbed 13.2% to settle at $4.38 after gaining over 15% on Thursday.
• PaySign, Inc. PAYS climbed 12.9% to close at $3.32. PaySign shares climbed around 25% on Thursday following circulation of an earlier TipRanks article titled '3 "Strong Buy" Stocks Flirting With a Bottom' mentioning the stock.
• National Beverage Corp. FIZZ gained 12.3% to settle at $52.55after the company reported Q1 EPS and sales results were higher year over year.
• SEMrush Holdings, Inc. SEMR rose 12.1% to close at $31.32. Semrush named Andrew Warden as Chief Marketing Officer.
• A-Mark Precious Metals, Inc. AMRK gained 12% to settle at $58.29 following upbeat Q4 results.
• Cedar Realty Trust, Inc. CDR climbed 11.4% to close at $18.93 after the company reported dual-track review of strategic alternatives. The company also named Jennifer Bitterman Chief Financial Officer.
• Spark Networks SE LOV surged 11.3% to settle at $3.35.
• CareMax, Inc. CMAX gained 11% to close at $9.41. Cowen & Co. initiated coverage on CareMax with an Outperform rating and announced a price target of $14.
• Lava Therapeutics B.V. LVTX surged 10.8% to settle at $6.49.
• NGM Biopharmaceuticals, Inc. NGM rose 9.9% to close at $23.36.
• ironSource Ltd. IS surged 9.8% to settle at $11.51.
• CPI Card Group Inc. PMTS gained 8.8% to close at $35.12.
• UP Fintech Holding Limited TIGR gained 8.6% to close at $14.53 after reporting Q2 results.
• SOS Limited SOS gained 8.5% to close at $2.80 after the company reported that revenue in the first half of 2021 totaled $184.5 million, representing an increase of 17 times year over year.

Check out these big penny stock gainers and losers

Losers

• Kaival Brands Innovations Group, Inc. KAVL fell 46.3% to close at $5.48 on Friday after climbing over 20% on Thursday.
• Mersana Therapeutics, Inc. MRSN dipped 39.1% to close at $8.56. Investors reacted to interim data from the ovarian cancer Phase 1 trial evaluating Upifitamab Rilsodotin (UpRi, previously XMT-1536).
• Apellis Pharmaceuticals, Inc. APLS shares dipped 37.2% to close at $34.93 on Friday after the company reported mixed top-line results from the Phase 3 DERBY and OAKS studies evaluating intravitreal pegcetacoplan in 1,258 adults with geographic atrophy secondary to age-related macular degeneration. The OAKS study met the primary endpoint for both monthly and every-other-month treatment with pegcetacoplan, demonstrating a significant reduction in GA lesion growth of 22% and 16%, respectively, compared to pooled sham at 12 months. However the DERBY study did not meet the primary endpoint of GA lesion growth, showing a reduction of 12% and 11%, with monthly and every-other-month treatment, respectively, compared to pooled sham at 12 months.
• Virpax Pharmaceuticals, Inc. VRPX dropped 25.6% to close at $11.60. Virpax Pharmaceuticals filed for offering of 3.4 million shares of common stock.
• Impel NeuroPharma, Inc. IMPL shares fell 23.8% to close at $16.11 after the company reported pricing of $45.0 million public offering.
• Vallon Pharmaceuticals, Inc. VLON dropped 21.7% to settle at $7.58.
• Support.com, Inc. SPRT declined 19.3% to close at $21.00 after stockholders approved the merger with Greenidge Generation Holdings Inc.
• Clarus Therapeutics Holdings Inc. CRXT fell 18.1% to settle at $7.89.
• RLX Technology Inc. RLX declined 16.8% to settle at $5.74.
• Tuesday Morning Corporation TUEM fell 16.7% to close at $1.95. Tuesday Morning shares fell 45% on Thursday after the company reported downbeat Q4 earnings.
• RxSight, Inc. RXST fell 16.1% to close at $13.42.
• Immuneering Corporation IMRX dropped 14.5% to settle at $20.75. Immuneering, last week, reported a Q2 loss of $1.61 per share.
• Hippo Holdings Inc. HIPO fell 14.4% to close at $5.87. The company earlier reported a Gross Loss Ratio of 161% for the three months ended June 30.
• Xos, Inc. XOS dropped 14.2% to settle at $7.17.
• TMC the metals company Inc. TMC fell 13.7% to settle at $9.41.
• Humanigen, Inc.HGEN dropped 13.7% to close at $6.88. Jefferies downgraded Humanigen from Buy to Hold and lowered the price target from $37 to $9.
• SGOCO Group, Ltd. SGOC declined 13.1% to settle at $6.18.
• Lakeland Industries, Inc. LAKE fell 13% to close at $20.80 after reporting downbeat Q2 sales.
• Statera Biopharma, Inc. STAB declined 12.9% to settle at $3.78.
• Gevo, Inc. GEVO declined 12.7% to close at $6.93. Gevo and Chevron, last week, announced a letter of intent to jointly invest in building and operating one or more new facilities that would process inedible corn to produce sustainable aviation fuel.
• Maravai LifeSciences Holdings, Inc. MRVI shares dropped 11.8% to close at $47.08 after the company announced a 20 million share offering of Class A common stock by selling shareholders to be priced at $50 per share.
• Spire Global, Inc. SPIR declined 10.1% to close at $9.92.
• Sumo Logic, Inc. SUMO shares declined 9.5% to close at $18.21 after the company reported Q2 earnings results and issued Q3 guidance. Piper Sandler downgraded Sumo Logic from Overweight to Neutral and lowered the price target from $24 to $20.
• Teradata Corporation TDC fell 9.4% to close at $51.11. Several analysts raised their price targets on the stock.
• PharmaCyte Biotech, Inc. PMCB fell 9.1% to close at $3.59.
• The Kroger Co. KR fell 7.5% to close at $42.67despite reporting upbeat quarterly results.
• Traeger, Inc. COOK fell 6% to settle at $24.02 after the company reported Q2 earnings results.